Breaking News From Pharma & Bio Ingredients
July 2008
Posted on 2008-07-11 13:05:00
Newly Revised PhRMA code builds off previous 2002 version
Posted on 2008-07-11 08:42:00
Facility does not meet requirements for future business plans
Posted on 2008-07-11 08:28:00
Making ScinoPharm the first pharmaceutical active ingredient manufacturer in Taiwan to be qualified by PMDA.
Posted on 2008-07-10 15:31:00
$18.8 Billion Transaction Marks Pivotal Point in Dow’s Transformation
Posted on 2008-07-10 08:18:00
Americhem's larger color pallette helps Pharma Packaging meet enduser needs
Posted on 2008-07-09 16:02:00
The acquisition will allow Lilly to integrate SGX's structure-guided drug discovery platform into its drug discovery efforts.
Posted on 2008-07-01 08:15:00
Industry Leader in Generic Market Information Offers Newport Horizon Premium
June 2008
Posted on 2008-06-27 09:11:00
Barr Pharmaceuticals, Inc. subsidiary, Barr Laboratories, Inc., wins favorable ruling in U.S. District Court for Delaware
Posted on 2008-06-27 08:49:00
New Blue Inspection provides API Audits and checks GMPs
Posted on 2008-06-24 13:16:00
Barr and Bayer Sign Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
Posted on 2008-06-19 16:45:00
Kendle will be exhibiting and speaking at Drug Information Association (DIA) 44th Annual Meeting, June 22-26, 2008
Posted on 2008-06-19 16:42:00
The state-of-the-art facility began testing in May 2008
Posted on 2008-06-19 16:23:00
New Kansas Bioscience Authority (KBA) helps companies develop new treatments
Posted on 2008-06-19 15:44:00
BASF commits to voluntary compliance of current cGMPs for excipients
Posted on 2008-06-13 07:55:00
As the Japanese market opens up, businesses see more opportunity in the 2nd largest market
Posted on 2008-06-13 07:53:00
Company sells API business to 3i for $365 Million.
Posted on 2008-06-12 10:05:00
They are expected to be granted approval to market generic form of Diovan in 2012
Posted on 2008-06-12 09:59:00
AdreView, a a molecular imaging agent for the detection of neuroendocrine tumors is under priority review
Posted on 2008-06-12 08:08:00
This is Aurobindo's 70th approval from the FDA.
May 2008
Posted on 2008-05-29 12:49:00
New catalyst technology delivers higher productivity, cost savings and reduced waste for pharmaceutical companies.
Posted on 2008-05-21 10:55:00
AGI Therapeutics presented key findings for Rezular(TM) at Digestive Disease Week in San Diego
Posted on 2008-05-20 09:47:00
Google Health now publicly available, but privacy issues are still a concern.
Posted on 2008-05-16 09:27:00
Cancer Therapeutics Continue Double Digit Growth according to IMS Health
April 2008
Posted on 2008-04-30 08:03:00
Shreveport LA site manufactures OTC products for U.S. market
Posted on 2008-04-29 13:45:00
Batch yields expected to increase threefold
Posted on 2008-04-29 13:43:00
Peter Brandt to lead specialty pharmaceutical company
Posted on 2008-04-29 13:42:00
Lifts restriction on drug approvals
Posted on 2008-04-29 13:40:00
Generic versions of Abbott's Mavik
Posted on 2008-04-29 09:56:00
Agency seeks more info on ER niacin/laropiprant
Posted on 2008-04-29 08:02:00
The 5-Fluorouracil production facility is sold to Teva subsidiary
Posted on 2008-04-25 07:53:00
A new report by Research and Markets
Posted on 2008-04-03 07:27:00
Expands capacity at Basel facility
Posted on 2008-04-03 07:18:00
Bioscreen Testing provides data support
March 2008
Posted on 2008-03-11 07:16:00
A record level for the production of monoclonal antibodies
Posted on 2008-03-07 16:32:00
David P. Carberry is a 27-year Johnson & Johnson veteran
Posted on 2008-03-07 08:38:00
Purchases 75% of Hisyn Pharmaceutical Co. Limited.